by Stacey Johnson | Dec 27, 2013
If you are fortunate enough to have time off over the holiday season, I’ll wager that you may spend some of that time in front of the television. Call me a Grinch, but Christmas TV programming is something that I generally avoid. If, like me, you plan on...
by Lisa Willemse | Dec 6, 2013
> I’ve been thinking a lot about cancer lately: the mother of a good friend of mine is in the last stages of a terminal battle with pancreatic cancer and my godfather, a man with whom I share fond memories of practical jokes and summer farm vacations, was...
by Ben Paylor | Dec 5, 2013
> Just over two years ago I wrote about early reports from Dr. Roberto Bolli et al.’s SCIPIO trial running out of the University of Louisville in collaboration with the Harvard Medical School. Since this time, much has happened in the realm of cell therapy to treat...
by Sara M. Nolte | Nov 26, 2013
> In honour of Movember – men’s health awareness month – I’m going to talk about prostate cancer. Not in the usual way – PSA (prostate-specific antigen) screens and clinical exams – but rather, from the perspective of cancer stem cells (CSCs), and their role in...
by Mark Curtis | Nov 19, 2013
. Welcome to October’s Update from the Clinic. Interesting developments this past month included the release of Phase 1/2a data from Living Cell Technologies that provides a first look at the safety and efficacy of its DIABECELL® product. We also saw an approval for...
by Stacey Johnson | Nov 15, 2013
. Sometimes too much choice can be a bad thing. It paralyzes you. I was flummoxed by the many options available to me in selecting what to feature on Right Turn this week. Then it struck me: I have the perfect item right under my nose (so to speak). CCRM just launched...
Comments